Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress.
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index; 25 of the 37 sources its claims cite were checked for support.
Abstract
Background The bidirectional relationship between inflammatory bowel disease (IBD) flare-ups and depression/anxiety symptoms has prompted investigations into psychotherapy to improve health-related quality of life (HRQoL) by targeting depression and anxiety. Acceptance commitment therapy (ACT) is effective in improving symptoms of depression and anxiety in people with chronic diseases, yet minimal research has examined ACT's effectiveness for IBD. This study examines the feasibility, acceptability, and preliminary efficacy of the ACTforIBD program, an online program codesigned with consumers to deliver ACT to those with IBD. Methods Adults with IBD and symptoms of mild-moderate distress were randomized to ACTforIBD or an active control (psychoeducation) condition. Participants completed 8 weekly, 1-hour sessions, 4 of which were therapist facilitated. Feasibility was based on recruitment and retention and acceptability was derived from postprogram satisfaction measures. Preliminary efficacy was determined by group differences in rate of change in study outcomes from baseline to postprogram. Results Of 62 participants (89% women, 11% men; mean age 33 years), 55 completed the program (ACTforIBD: n = 26 [83.9%]; active control: n = 29 [93.5%]). Adherence and acceptability were high in the ACTforIBD group, with 80% of participants completing all self-directed modules and 78% of participants expressing satisfaction with the program. Significant and marginally significant group × time interactions were found for anxiety symptoms (b = -1.89; 95% confidence interval, -3.38 to -0.42) and psychological HRQoL (b = -0.04; 95% confidence interval, -0.07 to 0.01), showing decreased anxiety and increased psychological HRQoL in the intervention group. Conclusions ACTforIBD is feasible, acceptable, and improved anxiety symptoms, and psychological HRQoL. This highlights the need for a full-scale randomized controlled trial to further examine the program's efficacy.
Overview
CoChat Summary
## TL;DR
This pilot randomized controlled trial tested an online, consumer-coded ACT program for adults with IBD and mild-to-moderate distress, comparing it with psychoeducation. ACTforIBD was feasible and acceptable, and it showed preliminary benefits for anxiety and psychological HRQoL, but not for most other outcomes.
## Key findings
- Of 191 interested potential participants, 62 were randomized, and 55 completed the 8-week program; retention was 83.9% in ACTforIBD and 93.5% in the active control, with no significant difference in attrition between groups (χ21 = 0.36, P = .55).
- In the ACTforIBD group, 80% completed all self-directed modules, and 78% reported satisfaction with the program.
- The intervention showed significant or marginally significant group × time effects for anxiety symptoms (b = -1.89; 95% CI, -3.38 to -0.42; d = -0.76, P = .006) and psychological HRQoL (b = -0.04; 95% CI, -0.07 to 0.01; d = -0.67, P = .04), favoring ACTforIBD.
- A significant group × time interaction was also found for experiential avoidance/psychological inflexibility (b = -3.41; 95% CI, -6.95 to -0.29), with reductions in the ACTforIBD group and increases in the active control group.
## Methods
- Randomized, single-blind controlled pilot trial with 1:1 allocation to ACTforIBD or an active control psychoeducation program; both conditions had 8 weekly 1-hour sessions, 4 therapist-facilitated and 4 self-directed.
- Adults with IBD living in Australia or New Zealand who were over 18, English-literate, internet-accessible, and screened as having mild-to-moderate psychological distress on the K10 (scores 16-29) were eligible.
- Main analysis used intention-to-treat linear mixed models with Bayesian estimation in MPlus, comparing baseline and postintervention change between groups.
## Limitations
- The paper states that the sample was primarily female and highly educated, limiting generalizability to the broader IBD population.
- The sample had high comorbidity with other chronic health conditions, which the authors say may have influenced HRQoL and distress outcomes.
- The text also makes evident that the trial had only baseline and postintervention assessment for the main analysis, so longer-term effects and disease-course changes could not be assessed; the authors explicitly note that they were not in a position to observe changes in disease activity due to lack of follow-up data.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
20 Valid · 1 Not valid · 5 Not checked · 82 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Research has demonstrated that between 2 and 5 years of observations are required to draw meaningful conclusions of the impact of the intervention on disease course.39”
§ Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress > Discussion > Preliminary Efficacy
What the sources say
- Disputedcites [39] Mikocka-Walus, 2017, Cognitive-behavioural therapy for inflammatory bowel disease: 24-month data from a randomised controlled trial, Int J Behav Med. sourceExperimental — accuracy not yet measured
The Discussion says a 24-month follow-up is insufficient to capture the course of IBD and suggests that 5 to 10 years may offer more information. The Conclusions likewise say 24 months was not adequate. This contradicts the claim that 2 to 5 years is the required observation period. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“both trials made use of an inactive control group (eg, treatment as usual) rather than an active control group as a comparison.”
§ Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress > Introduction
What the sources say
- Supportedcites [12] Trindade, 2021, The LIFEwithIBD intervention: study protocol for a randomized controlled trial of a face-to-face acceptance and commitment therapy and Compassion-Based intervention tailored to people with inflammatory bowel disease, Front Psychiatry. source
The Introduction says the earlier ACT trial in IBD compared the intervention with treatment as usual (TAU). The Discussion explicitly calls the LIFEwithIBD trial’s TAU-only control inactive and says an active control should be used in future studies. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [13] Wynne, 2019, Acceptance and commitment therapy reduces psychological stress in patients with inflammatory bowel diseases, Gastroenterology source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This is particularly important when working with clients living with chronic illnesses such as IBD, in whom avoidance of activities is common due to the concerns associated with their symptoms.8”
§ Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress > Introduction
What the sources say
- Partly supportedcites [8] Trindade, 2016, Inflammatory bowel disease: The harmful mechanism of experiential avoidance for patients’ quality of life, J Health Psychol. sourceExperimental — accuracy not yet measured
The Discussion says IBD symptoms can prompt concerns about daily routines and that patients may respond with avoidance. But the paper studies avoidance of internal experiences, such as pain and worrying thoughts, rather than establishing that avoidance of activities is common. No page numbers are available in our copy. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“psychotherapy with a strong psychoeducation focus has been shown to have little to no effect on symptoms of depression and anxiety in people diagnosed with IBD,16”
§ Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress > Introduction
What the sources say
- Partly supportedcites [16] McCombie, 2013, Psychotherapy for inflammatory bowel disease: a review and update, J Crohns Colitis sourceExperimental — accuracy not yet measured
Sections 3.3.1 and 3.3.2 report no effect on anxiety in three of five studies and no effect on depression in two of four, but the other studies found benefits. The Discussion describes the evidence as mixed; it does not establish that psychotherapy with a strong psychoeducation focus specifically has little to no effect on both outcomes. (LLM, conf=0.85)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“these changes do not continue long term (eg, 18 months postintervention),5”
§ Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress > Introduction
What the sources say
- Partly supportedcites [5] Gracie, 2017, Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis, Lancet Gastroenterol Hepatol sourceExperimental — accuracy not yet measured
The Quality of Life results (p. 18) report that CBT improved quality of life at the end of therapy but that the benefit was lost at the final follow-up. The paper does not establish that this CBT benefit was lost specifically 18 months postintervention; its 18-month follow-up finding concerns psychological therapy in patients with active IBD (p. 13). (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
61 more claims · 8 with their cited sources checked
Create a free account to see all 108 claims and every source verdict.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 17
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies examining acceptance and values-based interventions in IBD delivered partially33 or fully13 digitally have demonstrated efficacy in significantly improving psychological distress and HRQoL.”
From Culturally Informed Digital Behavioral Intervention Development for Inflammatory Bowel Disease: A Qualitative Study (2025) · cites this paper as [33]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent findings have highlighted that ACT-based interventions seem to be efficacious in reducing symptoms of stress (Lavelle et al., 2022), depression and anxiety (Romano et al., 2023) as well as feasible and well-accepted by adults living with IBD (Dober et al., 2021; Lavelle et al., 2022; Romano et al., 2023).”
From Randomized controlled trial of an Acceptance and Commitment Therapy and compassion-based group intervention for persons with inflammatory bowel disease: the LIFEwithIBD intervention (2024) · cites this paper as Romano et al., 2023
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress > Results > Feasibility and Acceptability
“Of the 55 participants that completed the program, 44 (80%) completed all 4 self-directed modules, 3 missed 1 module, 3 missed 2 modules, 1 missed 3 modules, and 2 participants did not engage with any of the self-directed modules.”
§ Feasibility, Acceptability, and Preliminary Efficacy of Acceptance Commitment Therapy for Adults Living With Inflammatory Bowel Disease and Distress > Results > Feasibility and Acceptability
“55 completed the 8-week program (ACTforIBD, n = 26; active control, n = 29), resulting in a retention rate of 83.9% for the experimental group and 93.5% for the active control condition.”
Citations
Cites
Lovibond, P. F., & Lovibond, S. H. (1995) · Behaviour Research and Therapy · doi:10.1016/0005-7967(94)00075-u · Cited by 14,523 · cited 1×
“The DASS-21 26 consists of 21 items measuring 3 subscales: depression, anxiety, and stress.”
BackgroundDevelopment and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011) · Quality of Life Research · doi:10.1007/s11136-011-9903-x · Cited by 9,795 · cited 1×
“HRQoL: EQ-5D-5L The EQ-5D-5L 29 consists of 6 items assessing the following domains of HRQoL: mobility, self-care, regular activity, pain, depression/anxiety (termed psychological HRQoL throughout this article to minimize conflation with the DASS), and an overall health item.”
MethodThe brief resilience scale: Assessing the ability to bounce back
Smith, B. W., Dalen, J., Wiggins, K., Tooley, E., Christopher, P., & Bernard, J. (2008) · International Journal of Behavioral Medicine · doi:10.1080/10705500802222972 · Cited by 6,439 · cited 1×
“The Brief Resilience Scale 33 consists of 6 items measuring resilience.”
MethodBond, F. W., Hayes, S. C., Baer, R. A., Carpenter, K. M., Guenole, N., Orcutt, H. K., Waltz, T., & Zettle, R. D. (2011) · Behavior Therapy · doi:10.1016/j.beth.2011.03.007 · Cited by 3,950 · cited 2×
“To assess whether ACT mechanisms were acquired as a function of the ACTforIBD program, the Acceptance and Action Questionnaire-II (AAQ-II) 34 was used.”
MethodPsychometric properties of the credibility/expectancy questionnaire
Devilly, G. J., & Borkovec, T. D. (2000) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/s0005-7916(00)00012-4 · Cited by 2,295 · cited 2×
“12,25 This could suggest that the accessibility of the program may not have been an incentive for people in this population and may not have been perceived as a solution to overcoming some of the proposed barriers to treatment that we had outlined previously, such as limited access to treatment and…”
BackgroundMethodInterpreting scores on the Kessler Psychological Distress Scale (K10)
Andrews, G., & Slade, T. (2001) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1467-842x.2001.tb00310.x · Cited by 2,021 · cited 1×
“Overall, it is a valid and reliable measure 21 and an efficient way to ensure that study participants were likely to be experiencing some level of anxiety or depressive symptoms prior to entering the study.”
BackgroundWhitehead, A. L., Julious, S. A., Cooper, C. L., & Campbell, M. J. (2016) · Statistical Methods in Medical Research · doi:10.1177/0962280215588241 · Cited by 1,936
Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases
Daut, R. L., Cleeland, C. S., & Flanery, R. C. (1983) · Pain · doi:10.1016/0304-3959(83)90143-4 · Cited by 1,562 · cited 1×
“One item derived from the Wisconsin Brief Pain Questionnaire 31 asked participants to rate the level of pain that they had experienced in the last 7 days.”
MethodBoot, W. R., Simons, D. J., Stothart, C., & Stutts, C. (2013) · Perspectives on Psychological Science · doi:10.1177/1745691613491271 · Cited by 670 · cited 1×
“14,15 Importantly, the type of treatment used in an active control group should be a known ineffective treatment for the outcomes of interest in a given population so as not to produce a separate intervention effect.”
BackgroundMikocka-Walus, A., Knowles, S. R., Keefer, L., & Graff, L. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000620 · Cited by 567
Self-citationHann, D. M., Jacobsen, P. B., Azzarello, L. M., Martin, S. C., Curran, S. L., Fields, K. K., Greenberg, H., & Lyman, G. H. (1998) · Quality of Life Research · doi:10.1023/a:1024929829627 · Cited by 525 · cited 1×
“The Fatigue Symptom Inventory 30 interference subscale measures participants’ perception of how fatigue interferes with their quality of life.”
BackgroundQuality of life in inflammatory bowel disease: a systematic review and meta-analyses—part I
Knowles, S. R., Graff, L. A., Wilding, H., Hewitt, C., Keefer, L., & Mikocka-Walus, A. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx100 · Cited by 503
Self-citationHann (1998) · Quality of Life Research · doi:10.1023/a:1008842517972 · Cited by 500
The truly remarkable universality of half a standard deviation: confirmation through another look
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2004) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.4.5.581 · Cited by 490
Graham, C. D., Gouick, J., Krahé, C., & Gillanders, D. (2016) · Clinical Psychology Review · doi:10.1016/j.cpr.2016.04.009 · Cited by 476 · cited 1×
“9 The focus on acceptance is one way in which ACT is distinct from CBT and may also yield more favorable and long-lasting results compared with CBT when it comes to improving HRQoL in those living with IBD.”
ResultWhat Does the Acceptance and Action Questionnaire (AAQ-II) Really Measure?
Wolgast, M. (2014) · Behavior Therapy · doi:10.1016/j.beth.2014.07.002 · Cited by 421 · cited 1×
“38 The significant effect seen in the intervention group suggests that ACTforIBD may be effective at reducing anxiety symptoms over time relative to receiving basic psychoeducation.”
BackgroundQuality of life in inflammatory bowel disease: a systematic review and meta-analyses—part II
Knowles, S. R., Keefer, L., Wilding, H., Hewitt, C., Graff, L. A., & Mikocka-Walus, A. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy015 · Cited by 416
Self-citationBi-directionality of brain–gut interactions in patients with inflammatory bowel disease
Gracie, D. J., Guthrie, E. A., Hamlin, P. J., & Ford, A. C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.027 · Cited by 408 · cited 1×
“3,4 In light of the bidirectional link between disease symptoms and psychological symptoms, research has looked to psycho-therapy as a means of addressing and improving HRQoL in people living with IBD by targeting symptoms of depression and anxiety.”
BackgroundGracie, D. J., Irvine, A. J., Sood, R., Mikocka-Walus, A., Hamlin, P. J., & Ford, A. C. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30206-0 · Cited by 271 · cited 2×
“5 The rationale behind this approach is that improved psychological well-being may have flow-on effects to predict less frequent IBD flare-ups and improve HRQoL.”
BackgroundSelf-citationKhanna, R., Zou, G., D'Haens, G., Feagan, B. G., Sandborn, W. J., Vandervoort, M. K., Rolleri, R. L., Bortey, E., Paterson, C., Forbes, W. P., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13001 · Cited by 242 · cited 1×
“The Patient-Reported Outcome–2 28 was adapted to measure the current activity of Crohn’s disease.”
MethodFairbrass, K. M., Lovatt, J., Barberio, B., Yuan, Y., Gracie, D. J., & Ford, A. C. (2022) · Gut · doi:10.1136/gutjnl-2021-325985 · Cited by 225
Feros, D. L., Lane, L., Ciarrochi, J., & Blackledge, J. T. (2013) · Psycho-Oncology · doi:10.1002/pon.2083 · Cited by 216 · cited 1×
“…has found ACT to be an effective form of psychotherapy for reducing symptoms of depression, anxiety, and stress in people living with other chronic diseases, such as cancer, 11 but only 2 trials to date have examined ACT in the context of IBD, 12,13 with only 1 trial having been completed thus far.”
BackgroundWynne, B., McHugh, L., Gao, W., Keegan, D., Byrne, K., Rowan, C., Hartery, K., Kirschbaum, C., Doherty, G., Cullen, G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.030 · Cited by 188 · cited 3×
“…has found ACT to be an effective form of psychotherapy for reducing symptoms of depression, anxiety, and stress in people living with other chronic diseases, such as cancer, 11 but only 2 trials to date have examined ACT in the context of IBD, 12,13 with only 1 trial having been completed thus far.”
BackgroundResultJairath, V., Khanna, R., Zou, G. Y., Stitt, L., Mosli, M., Vandervoort, M. K., D'Haens, G., Sandborn, W. J., Feagan, B. G., & Levesque, B. G. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13408 · Cited by 180 · cited 2×
“The Patient-Reported Outcome 27 (PRO2) was adapted to measure the current activity of ulcerative colitis.”
BackgroundBayesian Design and Analysis of Active Control Clinical Trials
Simon, R. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.00484.x · Cited by 131 · cited 1×
“14,15 Importantly, the type of treatment used in an active control group should be a known ineffective treatment for the outcomes of interest in a given population so as not to produce a separate intervention effect.”
BackgroundThe Manitoba IBD Index: Evidence for a New and Simple Indicator of IBD Activity
Clara, I., Lix, L. M., Walker, J. R., Graff, L. A., Miller, N., Rogala, L., Rawsthorne, P., & Bernstein, C. N. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.197 · Cited by 119 · cited 1×
“Randomization was stratified by IBD activity based on the Manitoba index, 20 with those reporting no to low activity (ie, scores of 1-3) being grouped into one category (designated “low”) and those reporting moderate-to-high activity (ie, scores of 4-6) being grouped into another category…”
MethodPsychotherapy for inflammatory bowel disease: a review and update
McCombie, A. M., Mulder, R. T., & Gearry, R. B. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.02.004 · Cited by 105 · cited 11×
“Five participants were lost to follow-up at the postintervention survey (ACTforIBD, n = 3; active control, n = 2).”
BackgroundInfluentialMcCombie, A., Gearry, R., Andrews, J., Mulder, R., & Mikocka-Walus, A. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000567 · Cited by 100 · cited 1×
“37,40 This suggests that hybrid designs that include a mixture of self-directed and therapist-led content are important for future work to incorporate in trials going forward.”
BackgroundSelf-citationSZIGETHY, E., WHITTON, S. W., LEVY-WARREN, A., DeMaso, D. R., WEISZ, J., & BEARDSLEE, W. R. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000142284.10574.1f · Cited by 92 · cited 1×
“12,17 It is important to also acknowledge the barriers that exist for people diagnosed with chronic conditions, such as IBD, that can make accessing psychotherapy more challenging.”
BackgroundMikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. M. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0278-2 · Cited by 86 · cited 2×
“37,40 This suggests that hybrid designs that include a mixture of self-directed and therapist-led content are important for future work to incorporate in trials going forward.”
BackgroundMikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. M. (2017) · International Journal of Behavioral Medicine · doi:10.1007/s12529-016-9580-9 · Cited by 78 · cited 1×
“39 This may be especially true for changes in disease activity as a function of improvements in symptoms of depression and anxiety, which themselves take time to manifest.”
BackgroundSelf-citationArtom, M., Czuber-Dochan, W., Sturt, J., Proudfoot, H., Roberts, D., & Norton, C. (2019) · Pilot and Feasibility Studies · doi:10.1186/s40814-019-0538-y · Cited by 48
The effect of psychotherapy on quality of life in IBD Patients: A systematic review
Paulides, E., Boukema, I., van der Woude, C. J., & de Boer, N. K. H. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa144 · Cited by 47 · cited 1×
“While cognitive behavioral therapy (CBT) has been found to reduce symptoms of depression and improve IBD HRQoL, 5,6 these changes do not continue long term (eg, 18 months postintervention), 5 indicating the need for further investigations.”
BackgroundAcceptance and Commitment Therapy
Mendoza-Ruvalcaba, N. M., von Humboldt, S., Arias‐Merino, E. D., & Leal, I. M. P. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_70 · Cited by 38
Acceptance and Commitment Therapy
Hayes, S. C., & Pierson, H. (2006) · Encyclopedia of Cognitive Behavior Therapy · doi:10.1007/0-306-48581-8_1 · Cited by 35
Trindade, I. A., Ferreira, C., & Pinto-Gouveia, J. (2016) · Journal of Health Psychology · doi:10.1177/1359105315587142 · Cited by 33 · cited 1×
“8 While both CBT and ACT deal with behavioral or experiential avoidance, the notion of acceptance included in ACT may be particularly suitable for overcoming avoidance associated with symptoms of IBD.”
BackgroundDober, M., Mikocka-Walus, A., Evans, S., Beswick, L., Emerson, C., & Olive, L. (2021) · Psychotherapy Research · doi:10.1080/10503307.2020.1813915 · Cited by 25 · cited 2×
“18 To date, there are no ACT programs that combine therapist-led sessions with self-directed online modules for this population, and thus ACTforIBD presents a novel approach to psychotherapy that is also accessible from any location, potentially cost-effective, and specialized for those living with…”
BackgroundSelf-citationTrindade, I. A., Pereira, J., Galhardo, A., Ferreira, N. B., Lucena-Santos, P., Carvalho, S. A., Oliveira, S., Skvarc, D., Rocha, B. S., Portela, F., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.699367 · Cited by 20 · cited 12×
“…has found ACT to be an effective form of psychotherapy for reducing symptoms of depression, anxiety, and stress in people living with other chronic diseases, such as cancer, 11 but only 2 trials to date have examined ACT in the context of IBD, 12,13 with only 1 trial having been completed thus far.”
BackgroundInfluentialEvans, S., Olive, L., Dober, M., Knowles, S., Fuller-Tyszkiewicz, M., O, E., Gibson, P., Raven, L., Gearry, R., McCombie, A., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-060272 · Cited by 15 · cited 2×
“A randomized single-blind controlled trial was conducted to assess the feasibility and preliminary efficacy of ACT for individuals living with IBD; see Evans et al 19 for a full feasibility protocol.”
BackgroundMethodSelf-citationSkvarc, D., Evans, S., Cheah, S., Cranney, M., German, B., Orr, R., Emerson, C., Olive, L., Beswick, L., Massuger, W., et al. (2022) · Complementary Therapies in Clinical Practice · doi:10.1016/j.ctcp.2022.101616 · Cited by 4
(2012) · doi:10.1037/17335-004 · Cited by 2
Research works printed but not linked: 2
- Schwarzer, 1995, Generalized self-efficacy scale, 35
- Muthén, 2021, Mplus User’s Guide
Cited by
Luo, K., Zhang, M., Tu, Q., Li, J., Wang, Y., Wan, S., Li, D., Qian, Q., & Lu, X. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03476-6 · Cited by 49
“Another study comparing ACT with psychoeducation as a control revealed that the Depression Anxiety and Stress Scale (DASS-21) score Table 3 The therapeutic effects of different methods on anxiety and depression in IBD significantly decreased in the ACT group [145].”
Naude, C., Skvarc, D., Maunick, B., Evans, S., Romano, D., Chesterman, S., Russell, L., Dober, M., Fuller-Tyszkiewicz, M., Gearry, R., et al. (2025) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003032 · Cited by 15
“Both have been found to have excellent feasibility and acceptability (42).”
Self-citationFerreira, C., Pereira, J., Skvarc, D., Oliveira, S., Galhardo, A., Ferreira, N. B., Lucena-Santos, P., Carvalho, S. A., Matos-Pina, I., Rocha, B. S., et al. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1367913 · Cited by 12
Walsh, E. H., Krause, A. J., Greytak, M., et al. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002839 · Cited by 11
Marchese, S. H., Naftaly, J. P., & Pandolfino, J. (2024) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh-24-10 · Cited by 8
“The intervention included eight online modules; the first three modules were led by a therapist, the following four were self-guided, and the last session was therapist-led (43,44).”
Influential
Metadata
- Authors
- Romano, D., Chesterman, S., Fuller-Tyszkiewicz, M., Evans, S., Dober, M., Gearry, R., Gibson, P. R., Knowles, S., McCombie, A., O, E., Olive, L., Raven, L., Van Niekerk, L., & Mikocka-Walus, A.
- Affiliations
- Deakin University (AU)
- School of Psychology, Deakin University , Geelong, Victoria , Australia
- University of Otago (NZ)
- The Alfred Hospital (AU)
- Swinburne University of Technology (AU)
- Health New Zealand (NZ)
- Faculty of Health, Deakin University , Burwood, Victoria , Australia
- Crohn's & Colitis Australia (AU)
- School of Psychological Sciences, University of Tasmania , Hobart, Tasmania , Australia
- Corresponding author
- Romano, Daniel
- ORCID
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-07-21
- Volume
- 30
- Issue
- 6
- Pages
- 911-921
- ISSN
- 1078-0998 (ISSN-L)
- 1536-4844
- PMC
- PMC11144983
- OpenAlex
- W4384924795
- Cited by
- 20
- References
- 40
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 7
- FWCI
- 4.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Inflammatory Bowel Diseases (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Litwin IBD Pioneers (#828660)
- Crohn's and Colitis Foundation of America (#828660)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Mindfulness and Compassion Interventions
- Social Sciences › Psychology › Applied Psychology › Digital Mental Health Interventions
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- inflammatory bowel disease
- MeSH terms
- Psychological Distress, Adult, Anxiety, Depression, Feasibility Studies, Female, Humans, Male, Middle Aged, Patient Acceptance of Health Care, Quality of Life, Inflammatory Bowel Diseases, Treatment Outcome, Acceptance and Commitment Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
